JBC INTERFERin siRNA transfection reagent

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on August 10, 2001
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
276/33/31124    most recent
M103866200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Riballo, E.
Right arrow Articles by Kysela, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Riballo, E.
Right arrow Articles by Kysela, B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print May 10, 2001
J. Biol. Chem, 10.1074/jbc.M103866200
Submitted on April 30, 2001
Revised on May 10, 2001
Accepted on May 9, 2001

Cellular and biochemical impact of a mutation in DNA ligase IV conferring clinical radiosensitivity

Enriqueta Riballo, Aidan J. Doherty, Yan Dai, Thomas Stiff, Marjorie A. Oettinger, Penny A. Jeggo, and Boris Kysela

MRC CMU, University of Sussex, Brighton BN1 9RR

Corresponding Author: b.kysela{at}sussex.ac.uk

DNA ligase IV functions in DNA non-homologous end-joining, V(D)J recombination and during brain development. We previously reported a homozygous mutation (R278H) in DNA ligase IV in a developmentally normal leukaemia patient who overresponded to radiotherapy. The impact of this hypomorphic mutation has been evaluated using cellular, biochemical and structural approaches. Structural modelling using T7 DNA ligase predicts that the activity and conformational stability of the protein is likely to be impaired. We show that wild type DNA ligase IV/Xrcc4 is an efficient double-stranded ligase with distinct optimal requirements for adenylate complex formation versus rejoining. The mutation impairs the formation of an adenylate complex as well as reducing the rejoining activity. Additionally, it imparts temperature-sensitive activity to the protein consistent with the predictions of the structural modelling. At the cellular level, the mutation confers a unique V(D)J recombination phenotype affecting the fidelity of signal join formation with little effect on the frequency of the reaction. These findings suggest that hypomorphic mutations in ligase IV may allow normal development and but confer marked radiosensitivity.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
L. Liang, L. Deng, S. C. Nguyen, X. Zhao, C. D. Maulion, C. Shao, and J. A. Tischfield
Human DNA ligases I and III, but not ligase IV, are required for microhomology-mediated end joining of DNA double-strand breaks
Nucleic Acids Res., June 1, 2008; 36(10): 3297 - 3310.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Enders, P. Fisch, K. Schwarz, U. Duffner, U. Pannicke, E. Nikolopoulos, A. Peters, M. Orlowska-Volk, D. Schindler, W. Friedrich, et al.
A Severe Form of Human Combined Immunodeficiency Due to Mutations in DNA Ligase IV.
J. Immunol., April 15, 2006; 176(8): 5060 - 5068.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Damaraju, D. Murray, J. Dufour, D. Carandang, S. Myrehaug, G. Fallone, C. Field, R. Greiner, J. Hanson, C. E. Cass, et al.
Association of DNA Repair and Steroid Metabolism Gene Polymorphisms with Clinical Late Toxicity in Patients Treated with Conformal Radiotherapy for Prostate Cancer
Clin. Cancer Res., April 15, 2006; 12(8): 2545 - 2554.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
H. Wang, B. Rosidi, R. Perrault, M. Wang, L. Zhang, F. Windhofer, and G. Iliakis
DNA Ligase III as a Candidate Component of Backup Pathways of Nonhomologous End Joining
Cancer Res., May 15, 2005; 65(10): 4020 - 4030.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
P.-M. Girard, B. Kysela, C. J. Harer, A. J. Doherty, and P. A. Jeggo
Analysis of DNA ligase IV mutations found in LIG4 syndrome patients: the impact of two linked polymorphisms
Hum. Mol. Genet., October 1, 2004; 13(20): 2369 - 2376.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Kuhne, E. Riballo, N. Rief, K. Rothkamm, P. A. Jeggo, and M. Lobrich
A Double-Strand Break Repair Defect in ATM-Deficient Cells Contributes to Radiosensitivity
Cancer Res., January 15, 2004; 64(2): 500 - 508.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Iwabuchi, B. P. Basu, B. Kysela, T. Kurihara, M. Shibata, D. Guan, Y. Cao, T. Hamada, K. Imamura, P. A. Jeggo, et al.
Potential Role for 53BP1 in DNA End-joining Repair through Direct Interaction with DNA
J. Biol. Chem., September 19, 2003; 278(38): 36487 - 36495.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Kysela, A. J. Doherty, M. Chovanec, T. Stiff, S. M. Ameer-Beg, B. Vojnovic, P.-M. Girard, and P. A. Jeggo
Ku Stimulation of DNA Ligase IV-dependent Ligation Requires Inward Movement along the DNA Molecule
J. Biol. Chem., June 13, 2003; 278(25): 22466 - 22474.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
J. Smith, E. Riballo, B. Kysela, C. Baldeyron, K. Manolis, C. Masson, M. R. Lieber, D. Papadopoulo, and P. Jeggo
Impact of DNA ligase IV on the fidelity of end joining in human cells
Nucleic Acids Res., April 15, 2003; 31(8): 2157 - 2167.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Dai, B. Kysela, L. A. Hanakahi, K. Manolis, E. Riballo, M. Stumm, T. O. Harville, S. C. West, M. A. Oettinger, and P. A. Jeggo
Nonhomologous end joining and V(D)J recombination require an additional factor
PNAS, March 4, 2003; 100(5): 2462 - 2467.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Rief and M. Lobrich
Efficient Rejoining of Radiation-induced DNA Double-strand Breaks in Centromeric DNA of Human Cells
J. Biol. Chem., May 31, 2002; 277(23): 20572 - 20582.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
S. P. Jackson
Sensing and repairing DNA double-strand breaks
Carcinogenesis, May 1, 2002; 23(5): 687 - 696.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Arosio, S. Cui, C. Ortega, M. Chovanec, S. Di Marco, G. Baldini, A. Falaschi, and A. Vindigni
Studies on the Mode of Ku Interaction with DNA
J. Biol. Chem., March 15, 2002; 277(12): 9741 - 9748.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. Li, C. Nelsen, and E. A. Hendrickson
Ku86 is essential in human somatic cells
PNAS, January 22, 2002; 99(2): 832 - 837.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.